0001683168-22-000103.txt : 20220105
0001683168-22-000103.hdr.sgml : 20220105
20220105195418
ACCESSION NUMBER: 0001683168-22-000103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220105
DATE AS OF CHANGE: 20220105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hart Daniel R
CENTRAL INDEX KEY: 0001346342
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32839
FILM NUMBER: 22513223
MAIL ADDRESS:
STREET 1: 2642 MICHELLE DR., SUITE 200
CITY: TUSTIN
STATE: CA
ZIP: 62780
FORMER NAME:
FORMER CONFORMED NAME: Hart Daniel Ryan
DATE OF NAME CHANGE: 20051208
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avid Bioservices, Inc.
CENTRAL INDEX KEY: 0000704562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 953698422
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 2642 MICHELLE DRIVE, SUITE 200
CITY: TUSTIN
STATE: CA
ZIP: 92780
BUSINESS PHONE: 714.508.6100
MAIL ADDRESS:
STREET 1: 2642 MICHELLE DRIVE, SUITE 200
CITY: TUSTIN
STATE: CA
ZIP: 92780
FORMER COMPANY:
FORMER CONFORMED NAME: PEREGRINE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20001109
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE CORP/DE/
DATE OF NAME CHANGE: 19970924
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNICLONE INTERNATIONAL CORP
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2022-01-03
0
0000704562
Avid Bioservices, Inc.
CDMO
0001346342
Hart Daniel R
2642 MICHELLE DRIVE, SUITE 200
TUSTIN
CA
92780
0
1
0
0
Chief Financial Officer
Common Stock, $0.001 par value
2022-01-03
4
M
0
500
5.6600
A
27833
D
Common Stock, $0.001 par value
2022-01-03
4
S
0
500
29.0700
D
27333
D
Stock Option (right to buy)
5.6600
2022-01-03
4
M
0
500
0
D
2028-08-01
Common Stock
500
232380
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 15, 2021.
Stock option granted to the reporting person on August 1, 2018, vests in four (4) equal annual installments beginning August 1, 2019 and each year thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
/s/ Daniel R. Hart
2022-01-05